Trials / Completed
CompletedNCT03329989
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 158 (actual)
- Sponsor
- Endo Pharmaceuticals · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An open-label study of safety and effectiveness of EN3835 in the treatment of cellulite in adult women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Collagenase Clostridium Histolyticum | During 3 treatment visits 12 injections will be given per treatment area |
Timeline
- Start date
- 2017-11-17
- Primary completion
- 2018-09-05
- Completion
- 2018-09-05
- First posted
- 2017-11-06
- Last updated
- 2020-12-29
- Results posted
- 2020-11-23
Locations
11 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03329989. Inclusion in this directory is not an endorsement.